Premier Alternatives

Pulmotect

Houston, TX · Founded 2007 · Privately Held (backing)

Developer of a respiratory therapeutics technology intended to reduce morbidity and mortality in patients at risk of severe respiratory diseases. Pulmotect is based in Houston, TX and was founded in 2007. Its last known valuation is $59.3 million. It has raised $29.5 million across 6 recorded rounds; the latest was a $10.3 million early-stage round in Aug 2024.

Last price · $/share
—
Implied valuation
$59.3M
Total raised
$29.5M
Last round
Early Stage VC
Aug 2024

Pulmotect key facts

  • Developer of a respiratory therapeutics technology intended to reduce morbidity and mortality in patients at risk of severe respiratory diseases.
  • Pulmotect’s last known valuation is $59.3M.
  • It has raised $29.5M across 6 recorded rounds; the latest was Early Stage VC ($10.3M) in Aug 2024.
  • Notable investors include United States Department of War, SkyWalker Property Partners, Jefferson River Capital, Axil Capital Partners, Baylor Angel Network — 13 tracked in total.
  • Pulmotect has filed 12 Form Ds with the SEC since 2016, most recently Sep 2024 ($10.3M sold to 15 investors).
  • Status: Privately Held (backing).
Free account
More of Pulmotect with a free account
  • ·The complete investor list: 13 names
  • ·Watch Pulmotect: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Pulmotect funding rounds

6 rounds
Aug 2024Early Stage VC$10.3MSEC filing▮
May 2023Debt$1.5MSEC filing▮
Jan 2022Debt$3.7MSEC filing▮
Mar 2021Seed Round$3.5MSEC filing▮
Feb 2018Early Stage VC$6.1MSEC filing▮
Full funding history →

Pulmotect valuation

Pulmotect's last known valuation is $59.3 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How much has Pulmotect raised?

Pulmotect has raised $29.5 million across 6 recorded rounds since 2016. The largest was a $6.1 million early-stage round in Feb 2018; the most recent was a $10.3 million early-stage round in Aug 2024.

Pulmotect has filed 12 Form Ds with the SEC since 2016, most recently in Sep 2024 ($10.3 million sold to 15 investors).

Pulmotect investors

13 investors are on record for Pulmotect, including United States Department of War, SkyWalker Property Partners, Jefferson River Capital and Axil Capital Partners. The early-stage round in Aug 2024 drew 15 investors.

About Pulmotect

Developer of a respiratory therapeutics technology intended to reduce morbidity and mortality in patients at risk of severe respiratory diseases. The company's therapeutics technology stimulates the body's natural defenses to provide broad-spectrum, fast-acting protection against bacterial pneumonia, influenza, fungal pneumonia and Class A bioterror agents, enabling caregivers to prevent and treat respiratory infections.

Sector
Healthcare
HQ
Houston, TX, United States
Founded
2007
Employees
10
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.

Valuation on record
$59.3M

Pulmotect’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.